Jereme M Sylvain sold $517k of DXCM
EVP, Chief Financal Officer at DEXCOM INC. 7,000 shares at an average of $73.83, traded Mar 10, 2025, filed Mar 11, 2025.
Score components
- +22RoleCFO
- +18Trade size$517k at market
- 0Share of holdings soldSold 4.9% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001093557-25-000062, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 8, 2025 | AGrant or award Common Stock10b5-1 | +35,906 | $0.00 | $0 | 119,684 | Mar 11, 2025 |
| Mar 8, 2025 | AGrant or award Common Stock10b5-1 | +22,798 | $0.00 | $0 | 142,482 | Mar 11, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stock10b5-1 | -2,670 | $73.22 | $195k | 139,812 | Mar 11, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stock10b5-1 | -3,203 | $74.04 | $237k | 136,609 | Mar 11, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stock10b5-1 | -1,127 | $74.70 | $84k | 135,482 | Mar 11, 2025 |
Related signals
Other insiders at DEXCOM INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | DEXCOM INC | Sadie Stern EVP Chief People & Culture Off | $221k 2,565 shares | -2% | |
| 36Weak | DEXCOM INC | Nicholas Augustinos director | $680k 8,089 shares | -22% | |
| 21Weak | DEXCOM INC | Michael Jon Brown EVP Chief Legal Compliance Off | $143k 1,700 shares | -2% | |
| 31Weak | DEXCOM INC | Jereme M Sylvain EVP, Chief Financal Officer | $303k 3,638 shares | -2% | |
| 20Weak | DEXCOM INC | Sadie Stern EVP, Chief HR Officer | $125k 1,466 shares | -1% | |
| 16Weak | DEXCOM INC | Michael Jon Brown EVP, Chief Legal Officer | $41k 500 shares | -1% | |
| 23Weak | DEXCOM INC | Mark G Foletta director | $229k 2,750 shares | -5% | |
| 33Weak | DEXCOM INC | Nicholas Augustinos director | $518k 6,290 shares | -16% | |
| 26Weak | DEXCOM INC | Michael Jon Brown EVP, Chief Legal Officer | $843k 10,000 shares | -9% | |
| 21Weak | DEXCOM INC | Sadie Stern EVP, Chief HR Officer | $526k 6,184 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.